EVGN – evogene ltd. - ordinary shares (US:NASDAQ)
Stock Stats
News
Evogene Reports Third Quarter 2024 Financial Results
Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results [Yahoo! Finance]
Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results
Evogene Ltd. (NASDAQ: EVGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Lavie Bio Announces Commercial Expansion of Yalos® as Seed-Treatment for Soybean, Following Successful Field Trials
Form 424B3 Evogene Ltd.
Form 6-K Evogene Ltd. For: Nov 21
Form SC 13G/A Evogene Ltd. Filed by: SILVERARC CAPITAL MANAGEMENT, LLC
Form 424B3 Evogene Ltd.
Form EFFECT Evogene Ltd.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.